Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS2549303 A
Publication typeGrant
Publication dateApr 17, 1951
Filing dateApr 20, 1949
Priority dateApr 20, 1949
Publication numberUS 2549303 A, US 2549303A, US-A-2549303, US2549303 A, US2549303A
InventorsJohn H Friden
Original AssigneeBristol Lab Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Inhaler for crystalline pencilllin or the like
US 2549303 A
Abstract  available in
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

133551 .1; H FRED-EN 2,549,303

EUR PENIGILLIN OR THE Filed April 2c 1949 K I 3s I lllllll! lllllllllllillllllllll INVEN TOR.

JOHN. H. F RIDEN ATTORNEY.

Patented Apr. 17, 1951 OR THE LIKE John H. Friden, Maplewood, N. J., assignor to Bristol Laboratories, Inc., Syracuse, N. Y., a

corporation of New York Application April 20, 1949, Serial No. 88,504

This invention relates to devices for the inhalationof relatively dry powdered medicaments, 'such as crystalline penicillin.

Inhalers constructed in accordance with this invention consist of two telescopically arranged basic units. One of the units is in the nature of a cartridge comprising a base, an upstanding, generally cylindrical tubular side wall that defines, with the base, a compartment for dry finely divided medicinal dust or powder, such as crystalline penicillin. A rupturable wall is disposed across the upper end of the tubular side wall to hermetically seal the medicinal powder within the compartment." l

The second unit comprises a body having a downwardly projecting, preferably frusto-conical extension at its lower end and a depending flange or tubular wall concentric with and spaced from the extension. The unit is provided with a pas* sage extending through the body and its exten sion. At the time of assembly, the tubular side Wall of the first unit is inserted in the flange of the second unit with its rupturable top wall po sitioned below the extension and spaced slightly therefrom.

-As will be explained in detail further along, the inhaler of this invention may have a single tip by which the medicament may be administered orally or through a nasal passage. It is within the purview of the invention to provide a pair of tips adapted, respectively, for nasal or oral administration, there being suitable valve means and associated devices for permitting the flow of air bearing the medicament through the selected tip.

It is the primary object of the invention to pro vide an inhaler for crystalline penicillin'or the like that is simple and compact in construction and capable of accomplishing its intended functions in an efiicient and trouble-free manner.

Another object of the invention is to provide an'inhaler for finely powdered medicament that is inexpensive in manufacturing cost.

The invention has for another object the provision of an inhaler adapted to readily apply dry finely divided medicaments, such as crystalline penicillin, to the surfaces of respiratory passages, such as the throat, the bronchial tube, and nasal passages.

The foregoing objects, as well as other objects, together with the advantages of the invention, will be' readily understood by persons skilled in the art upon reference to the following detailed description, taken in conjunction with the annexed drawing, which respectively describe and 9 Claims. (Cl. 128-206) illustrate preferred forms of inhalers constructed in accordance with the invention.

In the drawing: Figure 1 is a view in elevation of one form of inhaler embodying the invention, the basic units thereof being shown in spaced-apart relation;

Figure 2 is a central vertical cross-sectional view of the inhaler shown in Figure 1, with the parts assembled in one relative position; Figure 3 corresponds to Figure 2, and shows the parts in another relative position;

Figure 4 is a view in side elevation of a modified form of the invention and corresponds generally to Figure 1;

Figure 5 is a top plan view of the device shown in Figure 4;

Figure 6 is a central cross-sectional view in enlargement of the inhaler of Figure 4, with the parts assembled in one relative position; and

Figure 7 is a view in enlargement taken along line 1--1 of Figure 6.

Referring now to the drawing, wherein like reference numerals denote corresponding parts throughout the several views, the inhaler shown in Figures 1, 2 and 3 includes a first unit or cartridge III that comprises a circular base or bottom wall l2, having peripheral serrations, as indicated at I 4, to permit firm gripping by the user. Integral with the base is a generally cylindrical tubular side Wall l6, defining, with the base, a compartment 18' for containing a quantity of powdered medicament 20, such as crystalline penicillin. The base and tubular side wall are preferably formed of a suitable transparent plastic material that will not contaminate or adversely afiect the medicament contained therein. A rupturable diaphragm or top wall 22, made of a suitable rubber, plastic or the like, is disposed across the upper end of tubular side wall [6 and serves to hermetically seal the medicament within compartment l8.

Mounted on and frictionally engaging cartridge III is a second unit 24, which is also preferably made of a suitable plastic material. Unit 24 comprises a body 26, rounded at its upper end or tip to permit insertion in a nostril or in the mouth of a user and having a downwardly tapering *frusto-conical extension 28 at its lower end. As is best shown in Figures 2 and 3, an upwardly flaring central passage 30 extends through body 26 and its extension 28. Integral with body 26 is a depending flange or tubular member 32 that is concentric with and spaced from extension 28 and projects below the end of the extension. A plurality of angularly spaced grooves 34 are formed along the inner surface of tubular member 32 and connect with corresponding grooves 36 in the bottom of body 23, thereby establishing communication between the exterior of the device and the space between tubular member 32 and extension 28 when the parts are in assembled position.

Tubular wall 16 is partly disposed in tubular member 32, there being sufficient frictional engagement between these elements to maintain the units in the relative position shown in Figure 2. To the end that this frictional engagement may be attained, the peripheral surface of tubular member l6 and/or the inner surface of tub ular member 32 is tapered slightly. With the parts in the position shown in Figure 2, units l and 24 may be separated by exerting sufi'lcient pull to overcome the friction between the units. Also, when a person is ready to use the inhaler, unit ll) may be protracted with respect to unit 24-; that is, moved from the position shown in Figure 2 to that shown in Figure 3. This causes frusto-conical extension 28 to pierce rupturable wall 22 and enter compartment !8. The parts having assumed the position shown in Figure 3, the upper end of body 23 is inserted in the 'mouth or in a nostril of theuser.

For administration of the medicament through the mouth, air is first expelled from the lungs and the upper or tipend of body 26 is inserted between the lips and the lips are compressed. The user then inhales slowly and deeply through the mouth. This causes aspiration of air through the passages formed by recesses 34 and 36, the picking up of the particles of the medicament by the air, and the flow of the air and entrained medicament through passage 38 and thence into the mouth and communicating respiratory passages.

If adminstration is to be made through the nose, the user exhales and then inserts the tip end of body 26 into one nostril and closesthe other nostril by fingerpressure. The user then inhales slowly and deeply through his nose, drawing in a quantity of air and medicament through passage 35 in the same manner as outlined above in connection with oral administration of the medicament.

The form of the invention shown in Figures 4-7 i similar in a number of respects to that shown in Figures 1, 2 and 3, and includes a cartridge I!) that is preferably the same as the earlier described cartridge. The inhaler of Figures fi-T includes a second unit 38 comprising a body 39 having a pair of divergent upper ex tensionsM and 42. Extension 40 is generally circular in cross section and is intended for insertion in a nostril. Extension '42 is generally elliptical in cross section and is intended to be inserted in the mouth.

Body 39 is provided with a frusto-conical extension it and a depending circular flange or tubular member 46 that are preferably the same, in configuration and relativeposition, as extension 28 and tubular member 32 of the previously described form of the invention. Body 39 is also provided with a pair of oppositely disposed external depressions 48 to accommodate a user's fingers. v

A central blind bore 50 extends through extension 44 and terminates in body 39. A passage 52 communicates with bore 50 'and extends through extension 48. This passage consists of a lower portion of reduced diameter 54' and an upper portion of enlarged diameter 56 that is tapped at its outer end. A valve seat 58 is provided at the juncture of passage portions 54 and 56 for a ball check valve 60. A threaded plug 62 is positioned in the tapped end of extension 40 and has a central passage 64 establishing communication between passage 52 and the exterior of unit 38-. Plug 52 is provided at its outer end with a screw driver slot 66 to permit or its ready insertion or removal, and at its inner end with cross slots 68 (Figure '7) to permit outward flow of air at such times as ball valve 58 may be disposed across the inner end of passage 64.

Unit 38 is provided with another passage 10 corresponding to passage 52. Passage 10 communicates with bore 55 and extends through end portion 52 of body 39. Within passage 10 are a valve seat l2, a ball valve 14 and a threaded plug 16 which are the same as valve seat 58, ball valve 59 and plug 62, earlier described.

Units IE3 and 38 are assembled and maintained in assembled position in the same manner as outlined above in connection with the form of the invention shown in Figures 1, 2 and 3 Preparatory to using the inhaler shown in Figures 2-7, the user grips unit [0 with the fingersof one hand and unit 38 with the fingers of his other hand, and effects protraction of unit H] with respect to unit 38, thereby piercing rupturable wall 22 (Figure 6). It it is desired -to administer the powdered medicament nasally, the user inserts extension ll] in a nostril and inhales through that nostril, drawing air through recesses 18 and at, which air picks up particles of the medicament and then passe's, with the entrained medicament, upwardly through bore 56, passage 52, past ball valve til andth-rough passage 3 3. During nasal administration, ball valve H? is seated on its seat 12. Itit isdecided to administer the medicament orally, the user inserts extension 42 in his mouth and inhales through the mouth, air from the atmosphere and medicament entrained therein from compartment l8 flowing upwardly through bore 50, along passage '10, past valve 14, andthen through the passage in plug 16. It will be apparent that at such times, valve 66 remains on its seat 58.

From the foregoing, it is believed that the construction, operation and advantages of my present invention will be readily comprehended by persons skilled in the art. It is to be clearly understood, however, that the forms of the in vention herewith shown and described are be taken as preferred examples of the same, and that various changes in the shape, size and arrangement of parts may be resorted to without departing from the spirit of the invention as defined by the appended claims.

I claim:

1. In an inhaler, 'a hollow first unit for containing crystalline penicillin or the like, said first 'unit comprising a bottom wall, a tubular side wall and a ruptu'rableto'p wall hermetically sealing the penicillin "within ithe'uni't, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extendin below the lower end or the body, an "element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having -'a passage extending through the body and the element 'fo'i' ass- 08 establishing communication between the interior of the tubular member and the exterior of the body in the region ofthe upper end of the body, and means establishing communication between the exterior of the units and the space between the element and the tubular member.

2. In an inhaler, a hollow first unit for. cone taining crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, a downwardly tapering element carried by the body and projecting within the tubular member, said element being concentric with and spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, and means establishing communication between the exterior of the units and the space between the element and the tubular member.

3. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced. from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, said units defining a passage establishing communication between the exterior thereof and the space between the element and the tubular member.

4. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, a downwardly tapering element carried by the body and projecting within the tubular member, said element being concentric with and spaced from the tubular member, said tubular side wall being partly disposed within and frictionally engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, said units defining a passage establishing communi cation between the exterior. thereof and the space between the element and the tubular member.

5. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising anelongated body rounded at its upper end for insertion in a respiratory orifice, said body carrying an integral depending fiangeand a concentric frusto-conical extension at its lower end, said extension being positioned within and spaced from the flange, said body and extension having a central through passage, said second unit having at least one recessformed along the interior of the flange and the under surface of the body, said recess originatingat the lower end of the flange and terminating inwardly thereof, the units being telescopically arranged with the'tubular side wall of the first unit positioned partly within the flange of the second unit and with the rupturable top Wall directly below the extension.

6. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in a nostril and in the mouth, respectively, a tubular member integral with and extending below the lower end of the body, and an element carried by the body for rupturing the rupturable wall,

I said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a, corresponding extension, and means establishing communication between the exterior of the units and the space between the element and the tubular member.

7. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in a nostril and in the mouth, respectively, a tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a corresponding extension, and a check valve in each of the pair of passages, each check valve permitting fluid flow upwardly through the bore and then through a corresponding passage while preventing fluid flow in a reverse direction, and means establishing communication between the exterior of the units and the space between the element and the tubular member.

8. In an inhaler, a hollow first unit for containing crystalline penicillin or the like,- said first unit comprising a, bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in 2. nostril and in the mouth, respectively, a, tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a corresponding extension, a ball check valve in each of the pair of passages, each ball check valve permitting fluid flow upwardly through the bore and then through a corresponding passage while preventing fluid flow in a reverse direction, and a removable plug at the free end of each extension, each plug having an opening establishing communication between the corresponding one of said pair of passages and the exterior of the extension said units defining a passage establishing communication be= tween the exterior thereof and the space between the element and the tubular member.

9. An inhaler in accordance with claim 8, wherein the element is frusto-conical and concentric with the tubular member and the tubular side wall frictionally engages the inner sur-' face of the tubular member.

JOHN H. FRIDEN.

REFERENCES CITED The following references are of record in the file of this patent:

UNITED STATES PATENTS Number Name Date 2,307,986 Bolte Jan. 12, 1943 2,478,715 Sehmitt Aug. 9, 1949'

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2307986 *Feb 15, 1940Jan 12, 1943BolteInsufflator
US2478715 *Jul 14, 1948Aug 9, 1949Vilbiss CoPowder blower
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3400714 *May 3, 1965Sep 10, 1968Brunswick CorpNasal cannula
US4005711 *Jan 13, 1975Feb 1, 1977Syntex Puerto Rico, Inc.Inhalation device
US4064878 *Oct 26, 1976Dec 27, 1977Syntex Puerto Rico, Inc.Inhalation device
US4095596 *Nov 26, 1976Jun 20, 1978Smithkline CorporationNasal inhaler
US4098273 *Nov 5, 1976Jul 4, 1978Syntex Puerto Rico, Inc.Inhalation device
US4105027 *Oct 26, 1976Aug 8, 1978Syntex Puerto Rico, Inc.Inhalation device
US5161524 *Aug 2, 1991Nov 10, 1992Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5349947 *Jul 15, 1993Sep 27, 1994Newhouse Michael TDry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
US5355873 *Apr 22, 1992Oct 18, 1994Bon F DelAn inhalation device and method having a variably restrictable air inlet that allows the inhalation force required to overcome a locking element to be changed
US5388572 *Oct 26, 1993Feb 14, 1995Tenax Corporation (A Connecticut Corp.)Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573 *Dec 2, 1993Feb 14, 1995Tenax CorporationDry powder inhalator medicament carrier
US5460173 *Mar 25, 1994Oct 24, 1995Tenax CorporationDry powder inhaler medicament carrier
US5483954 *Jun 10, 1994Jan 16, 1996Mecikalski; Mark B.Combination for administration of powdered medication
US5533502 *Nov 18, 1994Jul 9, 1996Vortran Medical Technology, Inc.Powder inhaler with aerosolization occurring within each individual powder receptacle
US5533505 *Mar 3, 1993Jul 9, 1996Astra AktiebolagDisposable inhaler
US5568807 *Jul 13, 1995Oct 29, 1996Mecikalski; Mark B.Air-flow control for an inhaler
US5575281 *Jul 13, 1995Nov 19, 1996Mecikalski; Mark B.Medicated package
US5660169 *Apr 12, 1995Aug 26, 1997Astra AktiebolagDisposable inhaler with pull-off seal
US5669378 *Dec 21, 1995Sep 23, 1997Pera; IvoInhaling device
US5673686 *Feb 2, 1995Oct 7, 1997Plurichemie AnstaltMedicament inhaler and method
US5785049 *Sep 21, 1994Jul 28, 1998Inhale Therapeutic SystemsMethod and apparatus for dispersion of dry powder medicaments
US6055979 *Apr 1, 1997May 2, 2000Ing. Erich Pfeiffer GmbhDosing and discharging device for flowable media including powder/air dispersions
US6089228 *Jan 8, 1998Jul 18, 2000Inhale Therapeutic SystemsApparatus and methods for dispersing dry powder medicaments
US6102036 *Jul 30, 1998Aug 15, 2000Smoke-StopBreath activated inhaler
US6234169 *Aug 14, 1998May 22, 2001Arthur SlutskyInhaler
US6257233May 14, 1999Jul 10, 2001Inhale Therapeutic SystemsDry powder dispersing apparatus and methods for their use
US6401712Apr 25, 1997Jun 11, 2002Astrazeneca AbInhaler
US6543448May 30, 2000Apr 8, 2003Inhale Therapeutic Systems, Inc.Apparatus and methods for dispersing dry powder medicaments
US6546929Jun 4, 2001Apr 15, 2003Inhale Therapeutic Systems, Inc.Dry powder dispersing apparatus and methods for their use
US6651341 *Oct 12, 2000Nov 25, 2003Microdrug AgFoil cutter
US6679256Dec 6, 2000Jan 20, 2004Nektar TherapeuticsSystems and methods for extracting powders from receptacles
US6681767May 1, 2000Jan 27, 2004Nektar TherapeuticsMethod and device for delivering aerosolized medicaments
US6722363Jun 22, 1999Apr 20, 2004Astrazeneca AbDevice for emptying cavities containing powder by means of suction
US6901929Dec 19, 2002Jun 7, 2005Nektar TherapeuticsAerosolization; comprises pressurization cylinders; drug delivery
US7305986Jul 21, 2000Dec 11, 2007Mannkind CorporationUnit dose capsules for use in a dry powder inhaler
US7422013Mar 9, 2005Sep 9, 2008Nektar TherapeuticsDry powder dispersing apparatus and methods for their use
US7464706Sep 4, 2003Dec 16, 2008Mannkind CorporationUnit dose cartridge and dry powder inhaler
US7744925May 20, 2005Jun 29, 2010Quadrant Drug Delivery LimitedInsulin and a sugar alcohol; powder for pulmonary delivery; inhalants; storage stability
US7780991May 20, 2005Aug 24, 2010Quadrant Drug Delivery Limitedfor ballistic administration of a bioactive material to subcutaneous and intradermal tissue, delivery vehicle being sized and shaped for penetrating the epidermis; vehicle further comprises a stabilizing polyol glass, in particular, trehalose
US7785631May 20, 2005Aug 31, 2010Quadrant Drug Delivery LimitedSolid dose delivery vehicle and methods of making same
US8146588Dec 3, 2007Apr 3, 2012Mannkind CorporationUnit dose capsules and dry powder inhaler
US8156936Nov 2, 2007Apr 17, 2012Mannkind CorporationUnit dose capsules and dry powder inhaler
US8161969Mar 21, 2008Apr 24, 2012Novartis AgDry powder dispersing apparatus and methods for their use
US8215300Apr 14, 2008Jul 10, 2012Mannkind CorporationUnit dose cartridge and dry powder inhaler
US8424518Jun 12, 2009Apr 23, 2013Mannkind CorporationDry powder inhaler and system for drug delivery
US8485180Mar 4, 2010Jul 16, 2013Mannkind CorporationDry powder drug delivery system
US8499757Jun 12, 2009Aug 6, 2013Mannkind CorporationDry powder inhaler and system for drug delivery
US8561609Dec 7, 2011Oct 22, 2013Respira Therapeutics, Inc.Dry powder inhaler
US8636001Jun 12, 2009Jan 28, 2014Mannkind CorporationDry powder inhaler and system for drug delivery
US8651104May 11, 2012Feb 18, 2014Respira Therapeutics, Inc.Bead-containing dry powder inhaler
US8671937Mar 15, 2012Mar 18, 2014Mannkind CorporationUnit dose capsules and dry powder inhaler
CN1859938BSep 3, 2004Oct 13, 2010曼恩坎德公司Unit dose cartridge and dry powder inhaler
EP0846009A1 *Sep 15, 1995Jun 10, 1998Inhale Therapeutic SystemsApparatus and methods for dispersing dry powder medicaments
WO1997040876A2 *Apr 25, 1997Nov 6, 1997Schuckmann Alfred VonInhaler
WO1999066974A2 *Jun 22, 1999Dec 29, 1999Schuckmann Alfred VonDevice for emptying cavities containing powder by means of suction
WO2004012802A1 *Dec 23, 2002Feb 12, 2004Laszlo BudaiInhaler apparatus for mitigating respiratory complaints
WO2005023348A2 *Sep 3, 2004Mar 17, 2005Mannkind CorpUnit dose cartridge and dry powder inhaler
Classifications
U.S. Classification128/203.15, D24/110, 128/203.21
International ClassificationA61M15/00
Cooperative ClassificationA61M15/0028, A61M2015/0036, A61M2202/064, A61M15/00, A61M2015/0016, A61M2015/0041
European ClassificationA61M15/00